Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 4557-4561, October 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, P.-S.
Right arrow Articles by Jones, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, P.-S.
Right arrow Articles by Jones, M.

Hyperthermia and Bleomycin Schedules on V79 Chinese Hamster Cell Cytotoxicity in Vitro1

Peck-Sun Lin2, Kathleen Hefter and Mark Jones

Therapeutic Radiology Department, Radiobiology Division, Tufts-New England Medical Center, Boston, Massachusetts 02111

The effect of sequence and timing of hyperthermia (43°) and bleomycin on Chinese hamster cells (V79) has been investigated. Hyperthermia preceding bleomycin treatment produced a greater cytotoxic effect than bleomycin treatment preceding hyperthermia. Furthermore, it appears that the combination of hyperthermia and bleomycin becomes less effective if the application of bleomycin is delayed. The enhancement of cytotoxicity with hyperthermia first may be related to the effect of heat on the intracellular bleomycin degradation ability and protein synthesis. V79 cells treated with a protein synthesis inhibitor, cycloheximide, before bleomycin (but not in the reversed sequence) also showed a markedly lower level of survival. As for hyperthermia treatment, pretreatment with cycloheximide did not change the uptake of bleomycin. These results suggest that hyperthermia and cycloheximide have increased the effectiveness of bleomycin and are consistent with the observation on chromosome damage induced by hyperthermia-bleomycin and cycloheximide-bleomycin treatments reported in the literature.

1 This investigation was supported by USPHS Grants CA 26897 and CA 28426 awarded by the National Cancer Institute, Department of Health and Human Services.

2 To whom requests for reprints should be addressed.

Received 11/29/82. Accepted 7/ 1/83.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.